University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 8 of 23
Biomarker Changes and Anxiolytic Effects-Phase 2
NCT04565145
Latent Aging Mechanisms in Pain and Sleep
NCT04683640
Physiology, Imaging and Modeling of Essential Tremor
NCT03811405
Pilot RCT Feasibility Study: Cancer and T2D
NCT04468243
Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
NCT04484259
Phentermine/Topiramate for Uric Acid Stones
NCT04621929
Efficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ Osteoarthritis
NCT04731233
Gut Organoid and Microbiome Interactions in Hypertension
NCT04497727
Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury
NCT04586712
Thumb Osteoarthritis: A Cross-Sectional Study of Mechanisms
NCT04104477
Cannabidiol and CES1 Interactions in Healthy Subjects
NCT04603391
The PACE-DLB Study
NCT04829656
Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
NCT04668144
PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment
NCT04634162
Mediterranean Diet Intervention to Improve Gastrointestinal Function in Parkinson's Disease a Randomized, Controlled, Clinical Trial
NCT04683900
Impact of Timing of PD Assessments on Measures of Platelet Reactivity in Patients Undergoing PCI Treated With Cangrelor
NCT04668495
Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support:
NCT03360019
Hydrogen Peroxide to the Wound Following Surgical Incision Affecting Cultures in Primary Shoulder Arthroplast
NCT04609306
TECPR2 Observational Study
NCT04485221
Driving Performance of People With Parkinson's Using Autonomous In-Vehicle Technologies
NCT04660500
Prevalence of Visual Dysfunction in Neurological Disorders
NCT04836715
Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI
NCT04483583
Deep Brain Stimulation Effects in Essential Tremor
NCT04581941
Improving Lactation Success in Mothers of Critically Infants
NCT04097860
Probiotic and Gastrointestinal Symptoms Due to Menstruation in Healthy Women
NCT04457401
Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
NCT04576819
Inhibitory Control Smartphone App
NCT04243759
Deep Brain Stimulation Effects in Dystonia
NCT04568681
Marijuana Use, Strength Training, and Alcohol Consumption (MUSTAC) Study
NCT04791917
Early Ambulation to Reduce Hospital Length of Stay
NCT04444453
Dealcoholized Muscadine Wine and Skin Health in Women
NCT04614753
Confirmatory Study of HFVI Guided Analgesic Administration in Surgical Subjects
NCT04049656
Generalized Hypersensitivity in Patients With Fibromyalgia Syndrome
NCT04415866
Dysphagia in Thoracic Surgical Patients
NCT04487028
Home Operations Utilizing Stimulation
NCT04484285
FLO2 for Recovery After SCI
NCT03833674
BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial
NCT05180747
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357
Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)
NCT04112043
A Trial to Test an Acceptance-based Therapy Program Among Adolescent Girls With Overweight/Obesity
NCT04484831
AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
NCT04472026
Intentional Pulpotomy to Preserve Hopeless Molars
NCT04385693
Pain Relief for OsteoArthritis Through Combined Treatment (PROACT)
NCT03884374
Repetitive Transcranial Magnetic Stimulation (rTMS) for Dystonia and Tremor
NCT04299087
A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics
NCT03843502
To Determine the Activity and Mechanisms of Cranberries to Attenuate Skin Photoaging and Improve Skin Health in Women
NCT04183920
Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
NCT03814317
Adaptability and Resilience in Aging Adults-2
NCT04068922
Burning Mouth Syndrome Mouth Guard Prospective Study
NCT04203134
Diaphragm Pacing in Individuals With Spinal Cord Injuries
NCT04179799
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.